Back to calendar
Myriad Genetics, Inc. (MYGN) Earnings
MYGN reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.20
Actual EPS: $-0.25
EPS surprise: -332.69%
Company overview
Market Cap$380.7M
PriceUSD 3.98
EPS (TTM)-1.20
52-week high8.50
52-week low2.74
SectorHealth Technology
IndustryMedical Specialties
Employees2,700